ArticleMolecular therapy. Nucleic acids2025

Potential ASO-based personalized treatment for Charcot-Marie-Tooth disease type 2S.

Sandra Smieszek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.